Akèy › Kolit Ulseratif › Texas › Tyler
Etid klinik pou Kolit Ulseratif nan Tyler, TX
14 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Tyler (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Ap rekriteFaz 3
- Tyler Research Institute ( Site 0294), Tyler
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Tyler Research Institute, Tyler
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ap rekriteFaz 1/2Volontè an sante akeyi
- Xencor Investigative Site, Tyler
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Site US-004, Tyler
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- Tyler Research Institute, LLC, Tyler
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ap rekriteFaz 3
- Tyler Research Institute, Tyler
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Ap rekriteFaz 2
- Tyler Research Institute, Tyler
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Tyler Research Institute, Tyler
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ap rekriteFaz 4
- Tyler Research Institute, LLC, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- Tyler Research Institute, LLC - Site Number: 8400095, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- Tyler Research Institute, LLC, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- Tyler Research Institute, LLC - Site Number: 8400095, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Ap rekriteFaz 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Tyler
Etid Kolit Ulseratif nan lòt vil
- New York City, NY23 etid
- Orlando, FL22 etid
- Miami, FL21 etid
- Houston, TX17 etid
- San Antonio, TX16 etid
- Chicago, IL15 etid
- Tacoma, WA15 etid
- San Diego, CA15 etid
- Colorado Springs, CO14 etid
- Los Angeles, CA13 etid
- St. Louis, MO13 etid
- Washington, DC12 etid
Lòt etid nan Tyler
- Kansè Poumon ki pa ti selil20 etid
- Maladi Crohn16 etid
- Kansè kolorektal8 etid
- Ensifizyans kadyak8 etid
- Kansè (tout kalite)7 etid
- Kansè ovè7 etid
- Kansè Endomèt6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè nan tete6 etid
- Kansè Metastatik5 etid
- Maladi Entestinal Anflamatwa5 etid
- Lukemi lenfositè kwonik5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.